Synta Pharmaceuticals
VerifiedInnovative, agile biopharmaceutical company focused on research, development and commercialization of novel oncology medicines that have the potential to change the lives of cancer patients.
Launch date
Market cap
-
Net debt
-
Enterprise valuation
$15—23m (Dealroom.co estimates Jan 2010.)
Lexington Kentucky (HQ)
Authorizing premium user...